Important pharmacy news and late-breaking industry information updated daily.

More and more companies are marketing direct-to-consumer (DTC) tests for a growing range of health conditions and traits directly to consumers online or in stores, including in pharmacies. But the kits are often marketed without the proper evidence to support the results, and little regulation exists.

FDA on Thursday requested that Eisai Inc. voluntarily withdraw its drug lorcaserin (Belviq, Belviq XR) after a safety clinical trial found an increased occurrence of cancer. Eisai has submitted a request to voluntarily withdraw the drug.

New research highlights the need to keep medications in their child-resistant containers. The study—which involved calls to five U.S. poison control centers by researchers from CDC, Emory University School of Medicine, and the Georgia Poison Center—is published in the Journal of Pediatrics.

The World Health Organization (WHO) has given a name to the illness caused by the new coronavirus: CoViD-19. The name stands for coronavirus disease 2019, the year when the illness was first detected.

The Trump administration's 2021 budget request delivered Monday to Congress includes a nearly 10% cut to HHS, although the requested cuts are not expected to win approval from the House of Representatives, which has the power of the purse and a Democratic majority. The budget request would trim funding for CDC by almost 16%.

On Monday, February 10, CDC released a FAQ resource on shared clinical decision-making recommendations. Access the FAQs at https://apha.us/ACIPfaqs.

A large-scale study of dental visits resulting in opioid prescriptions found that opioid overprescribing by dentists is common. Study results, published in the American Journal of Preventive Medicine, indicate that more than one-half of opioid prescriptions written by dentists exceed the 3-day supply recommended by CDC in its 2016 guidelines for acute dental pain management.

HHS says the U.S. government plans to spend up to $66 million in its initial response to the new coronavirus (2019-nCoV).

Toxicologists, health care practitioners, and others are noticing an alarming trend as physicians have begun prescribing fewer opioids: Gabapentin prescriptions and subsequent misuse of the painkiller have increased.

According to a new survey release February 6 from the National Community Pharmacists Association (NCPA), pharmacists seem split on how big a threat the new coronavirus is to the public. However, it’s a different story for their patients.